Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Dicerna Pharmaceuticals
480 Arsenal St., #120
Watertown, MA 02472
Phone: 617-621-8097
www.dicerna.com

Dicerna is a private, venture-backed biopharmaceutical company harnessing RNA interference (RNAi) to develop breakthrough, targeted therapeutics. Utilizing its Dicer Substrate Technology platform and EnCore delivery technology, Dicerna is developing a pipeline of programs to reach previously undruggable intracellular disease targets. The company has collaborations and alliances with global pharmaceutical companies and will continue to build on this momentum to advance its research and development efforts.

Key Contact
Name
Douglas Fambrough
Title
CEO
Funding Events

Date
Amount
Type
Investors
08/01/13 $60,000,000 Series C Abingworth
Brookside Capital
Deerfield Management Company, L.P.
Domain Associates
Omega Funds
RA Capital
SR One